SLAS Europe 2021 : Domain Therapeutics to present a poster about its powerful BRET-based platform dedicated to the study of immune checkpoint co-receptors.

Domain Therapeutics, a leading GPCR company in the field of immuno-oncology is glad to participate next week to SLAS Europe digital conference.
We are eager to share our latest poster with you and share more about Domain Therapeutics’ powerful BRET-based platform dedicated to the study of immune checkpoint co-receptors.
Thanks a lot to Alice GENTIL DIT MAURIN, Christel Franchet, Stephan Schann and Xavier Leroy for this promising poster !